Future of Health: Advanced Therapy Medicinal Products (ATMP)

-

Advanced Therapy Medicinal Products are biological pharmaceuticals based on cells, tissue, or genes. These pharmaceuticals are considered to be a very important part of future healthcare. Often it’s a one-time treatment where seriously ill patients are can be cured, hopefully with a lifelong effect. During this panel discussion we will talk about where we stand today, which challenges remain to be solved and what the future opportunities are.

New tools to explore disease mechanisms and facilitate drug development

-

Seminari: In order to understand disease mechanisms and how drugs interact with their target proteins, new tools are under constant development. Advancements in protein science have provided new novel methods for better understanding of human biology, improved diagnostics and more effective drug delivery.

New Project Manager at the Foundation

Welcome Kajsa Liljegren, who started a position as a Project Manager at Stockholm Science City on October 1.

"Sweden is a good place for innovation"

Johan Ödmark is Senior Adviser at SISP, Swedish Incubators & Science Parks. To develop world-leading offers in business development and collaborations within innovation, while the members' local and regional missions become national efforts, is a challenge for SISP.

From data to impact and business – create value through strategic management of intangible assets

 “Impact” – as in a positive, measurable societal change – has been something of a buzzword this autumn. Rightly so, in my opinion, since the urgency of meeting the global challenges is ever increasing. A closely related word is “innovation” – often interpreted as the process of successfully introducing something new on the market. If you add “social” to “innovation”, you will end up somewhere really close to “impact”. ISO TC 279 in the standard ISO 56000:2020 defines innovation as "a new or changed entity realizing or redistributing value".

Subscribe to